Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.18
Bid: 42.16
Ask: 42.24
Change: 0.56 (1.35%)
Spread: 0.08 (0.19%)
Open: 42.28
High: 42.40
Low: 42.12
Prev. Close: 41.62
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

20 May 2019 10:41

RNS Number : 5568Z
Assura PLC
20 May 2019
 

 

20 May 2019

 

Assura plc

 

Directorate Changes

 

Assura plc ("Assura" or the "Company"), the leading investor and developer of primary care properties, announces that David Richardson intends to retire as Non-Executive Director of the Company at the conclusion of the AGM on 2 July 2019. David was appointed in 2012 and served as Chair of the Audit Committee and Senior Independent Director. 

David indicated to the Board last year that he was considering retiring after seven years in the role. Accordingly, the Board initiated a search for a new non-executive director, who could provide possible succession for David and Jonathan Davies joined the board in June last year as a Non-Executive Director. The Board now intends to appoint Jonathan as Chairman of the Audit Committee and Senior Independent Director at the AGM. 

Ed Smith, Non-Executive Chairman, commented; "I would like to thank David on behalf of our shareholders and the Board for his fantastic contribution to Assura over 7 years. His experience and wisdom have been invaluable in ensuring strong growth in our business and sound Governance and we wish him well in his retirement from our Board." 

David Richardson commented; " It has been a pleasure to serve on the Board of Assura. The journey from a small company to a FTSE 250 one has been exciting and I am retiring happy in the knowledge that the Company has a strong Board and management team and that its finances and strategy are sound."

- Ends -

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Orla Ball

David Purcell

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2018, Assura's property portfolio was valued at £1,843 million.

 

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGURWAUPBUBU
Date   Source Headline
12th Jul 20227:00 amRNSAdditional Listing
11th Jul 20227:00 amRNSScrip Dividend Declaration
7th Jul 20228:07 amRNSHolding(s) in Company
6th Jul 20225:18 pmRNSDirector/PDMR Shareholding
6th Jul 20225:06 pmRNSHolding(s) in Company
6th Jul 20223:32 pmRNSResult of AGM
6th Jul 20228:57 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSTrading Update
16th Jun 20229:45 amRNSScrip Calculation Price
7th Jun 20227:00 amRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSAnnual Report & Notice of AGM
31st May 20221:58 pmRNSDirector/PDMR Shareholding
31st May 20227:00 amRNSNotice of Dividend
24th May 20227:00 amRNSAssura Full Year Results 2022
17th May 20225:41 pmRNSHolding(s) in Company
16th May 20224:36 pmRNSChange to year end results announcement date
12th May 20225:15 pmRNSHolding(s) in Company
12th May 20227:00 amRNSUpdated results presentation timing
9th May 20229:06 amRNSDirector/PDMR Shareholding
6th May 202211:46 amRNSHolding(s) in Company
4th May 20223:17 pmRNSHolding(s) in Company
4th May 20229:31 amRNSHolding(s) in Company
29th Apr 202211:58 amRNSTotal Voting Rights
29th Apr 202211:56 amRNSHolding(s) in Company
22nd Apr 20227:00 amRNSIssue of Consideration Shares
21st Apr 20223:01 pmRNSDirector/PDMR Shareholding
21st Apr 20227:00 amRNSNotice of Results & Investor Presentations
12th Apr 20228:50 amRNSHolding(s) in Company
11th Apr 202211:10 amRNSDirector/PDMR Shareholding
11th Apr 20228:47 amRNSHolding(s) in Company
11th Apr 20227:00 amRNSScrip Dividend Declaration
6th Apr 202210:30 amRNSStandard form for notification of major holdings
6th Apr 20227:00 amRNSIssue of Consideration Shares
1st Apr 20227:00 amRNSDevelopment Update
22nd Mar 202210:07 amRNSHolding(s) in Company
18th Mar 20221:49 pmRNSScrip Calculation Price
16th Mar 20227:00 amRNSDevelopment Update
8th Mar 20222:57 pmRNSHolding(s) in Company
8th Mar 20222:01 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSNotice of Dividend
9th Feb 20223:52 pmRNSHolding(s) in Company
9th Feb 20221:15 pmRNSDirector/PDMR Shareholding
1st Feb 20229:08 amRNSTotal Voting Rights
18th Jan 20223:14 pmRNSDirector/PDMR Shareholding
10th Jan 20227:00 amRNSScrip Dividend Declaration
10th Jan 20227:00 amRNSTrading Update
7th Jan 20223:41 pmRNSDirector/PDMR Shareholding
16th Dec 20219:27 amRNSScrip Calculation Price
8th Dec 20214:05 pmRNSHolding(s) in Company
7th Dec 202110:55 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.